Using genomics to improve Bacillus anthracis diagnostics and outbreak investigations by Ågren, Joakim
Using genomics to improve        
Bacillus anthracis diagnostics and 
outbreak investigations 
Joakim Ågren 
Faculty of Veterinary Medicine and Animal Science 
Department of Biomedical Sciences and Veterinary Public Health 
Uppsala 
 
and 
 
Department of Bacteriology, National Veterinary Institute, Uppsala 
  
Doctoral Thesis 
Swedish University of Agricultural Sciences 
Uppsala 2014 
Acta Universitatis agriculturae Sueciae 
2014:60 
ISSN 1652-6880 
ISBN (print version) 978-91-576-8068-6 
ISBN (electronic version) 978-91-576-8069-3 
© 2014 Joakim Ågren, Uppsala 
Print: SLU Service/Repro, Uppsala 2014
Cover: Scanning electron microscopy image of Bacillus anthracis spores. 
 
(photo: Joakim Ågren, SVA, and Leif Ljung, Uppsala University) 
 
Using genomics to improve Bacillus anthracis diagnostics and 
outbreak investigations 
Abstract 
The bacterium Bacillus anthracis causes the disease anthrax, primarily in herbivores 
but many mammals are susceptible to the disease. Its infective form is as a dormant 
spore that can lie in the soil for decades. Thus, in its cycle of infection, it spends most 
of the time in an inactive state and replication-induced DNA-mutations are therefore 
kept at a minimum. Partly due to these long periods of inactivity, all B. anthracis 
isolates found in the world are genetically very similar. This makes strain 
characterization difficult and requires high-resolution technologies. Bacillus anthracis 
also has similar DNA-content as other Bacillus spp. and therefore diagnostic cross-
reactions are not uncommon. 
Anthrax incidence has steadily declined in the world during the last century but there 
are still endemic areas. In 2008 and in 2011 Sweden suffered two large and costly 
outbreaks, most likely caused by the disturbance of old anthrax epizootic graves from 
the 1940s and 1950s. Several studies emanated from these outbreaks including how the 
bacteria in cows treated with penicillin developed penicillin resistance. 
Next-generation sequencing (NGS) has revolutionized the way DNA is sequenced 
and the whole genome (i.e., all the DNA) of a bacterium can now be sequenced in only 
a few days. In this doctoral thesis, NGS and genomics were used to improve our 
capability to deal with anthrax outbreaks. 
Genomic and genetic studies were applied to identify the non-anthrax Bacillus spp. 
available that were most closely related to B. anthracis. How well the strains could 
mimic B. anthracis in a model system for B. anthracis spores was evaluated and the 
best model strains found have since been used in exercises and as controls in real 
samples. For genome comparisons, a software was created that can compare the genetic 
content of several hundreds of bacterial genomes. This ensures a rapid characterization 
of an outbreak pathogen’s genome. The software was also used to in silico-compare all 
published anthrax PCR-assays to determine which assays that had the highest 
specificity. This workflow ensures that our molecular diagnostics are as specific for B. 
anthracis as possible. 
By using isolates from an anthrax outbreak, the mechanisms of beta-lactam 
resistance in B. anthracis were studied and chromosomal mutations in a negative sigma 
factor were found to be the cause. The genomic divergence of a strain during an 
outbreak was also studied to gain knowledge of the strengths and limitations of using 
NGS for epidemiological investigations. 
    In summary, this thesis describes different genomic approaches that have 
improved diagnostic methods, explained ambiguous antimicrobial resistance findings 
and enhanced the resolution of genomic epidemiological investigation to ensure a 
robust handling of future anthrax outbreaks. 
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The capacity to blunder slightly is the real marvel of DNA. Without this special 
attribute, we would still be anaerobic bacteria and there would be no music. 
 - Lewis Thomas  
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1 Background 
1.1 Bacillus anthracis 
Bacillus anthracis is a rod-shaped, Gram-positive, spore-forming aerobic 
bacterium that causes the disease anthrax (Mock & Fouet, 2001). The 
bacterium was intensively studied by Robert Koch and Louis Pasteur and in 
1876 Koch determined the full life cycle of the bacterium and it was the model 
for Koch’s postulates on the transmission of infectious disease (Sternbach, 
2003; Koch, 1876). 
The bacterium belongs to the large genus of Bacillus and it is often placed 
in the so-called Bacillus cereus group (B. cereus sensu lato), which is a sub-
group of closely related species (Daffonchio et al., 2000). The group comprises 
B. anthracis, B. cereus, B. mycoides, B. pseudomycoides, B. thuringiensis and 
B. weihenstephanensis. It has been proposed that B. anthracis, B. cereus and B. 
thuringiensis should form a single species, in which B. anthracis would be one 
lineage (Helgason et al., 2000) due to their close relatedness and the inability 
to fully differentiate all of them using 16S ribosomal RNA sequencing 
(Bavykin et al., 2004) or multilocus sequence typing (MLST) (Priest et al., 
2004). 
In contact with free oxygen, B. anthracis forms an endospore (Roth et al., 
1955), which has high levels of resistance to heat, drought, chemicals and UV-
light (Kim et al., 2004; Nicholson et al., 2000; Watson & Keir, 1994). These 
endospores are metabolically inactive and designed to survive for long periods 
of time until conditions are suitable and they can germinate into vegetative 
cells again. 
1.1.1 Closely related Bacillus spp. 
Genetically, the major difference between B. anthracis and some of the closely 
related B. cereus-group strains are the two big virulence plasmids pXO1 and 
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pXO2. The pXO1 plasmid (182 kb) encodes toxins (Okinaka et al., 1999) and 
the pXO2 plasmid (95 kb) encodes a protective poly-D glutamate capsule that 
is essential for virulence (Makino et al., 1989; Green et al., 1985; Uchida et al., 
1985). The chromosome of B. anthracis is 5.2 Mb and the main features 
discriminating it from the chromosomes of related Bacillus spp. are a nonsense 
mutation in the plcR gene (Agaisse et al., 1999) together with four prophages 
of which only one of them has been found in other Bacillus spp. (Sozhamannan 
et al., 2006; Read et al., 2003). The transcriptional activator PlcR is 
responsible for the expression of extracellular proteins such as hemolysins, 
enterotoxins and proteases in B. cereus and B. thuringiensis (Slamti et al., 
2004; Gohar et al., 2002). In B. anthracis the plcR gene product is truncated 
and non-functioning, which gives B. anthracis a different secretome than B. 
cereus (Sastalla et al., 2010). 
The terms ‘close neighbors’ or ‘near-neighbors’ are often used when 
describing strains of Bacillus spp. that are genetically very closely related to B. 
anthracis (Greenberg et al., 2010; Kolsto et al., 2009; Taitt et al., 2008). These 
strains have chromosomes which are highly similar to the B. anthracis 
chromosome and some of them also have virulence plasmids, which resembles 
the plasmids pXO1 and pXO2 (Klee et al., 2010; Hoffmaster et al., 2004). The 
close neighbors comprise strains of B. cereus and B. thuringiensis, which are 
species that can cause food-poisoning and have insecticidal properties, 
respectively (Stenfors Arnesen et al., 2008; Aronson et al., 1986). The genetic 
similarities of these strains are illustrated in Figure 1 where genomes from the 
B. cereus-group of differing relatedness have been compared using the 
Gegenees software (Ågren et al., 2012). 
There are also reports of close neighbors causing anthrax-like disease. In 
1987, the strain B. cereus G9241 caused anthrax-like pneumonia in welders in 
southern USA (Miller et al., 1997). The strain had a plasmid, which shared 
99.6 % similarity to the toxin-producing pXO1 plasmid and was confirmed to 
be virulent in a mouse model (Hoffmaster et al., 2004). In 2001-2002 in Côte 
d’Ivoire and in Cameroon in 2004, closely related isolates caused anthrax-like 
disease leading to death in four infected chimpanzees and in one gorilla. The 
isolates were clearly not typical B. anthracis as they were motile and resistant 
to the gamma phage (Klee et al., 2006), which B. anthracis is not. Genome 
sequencing of one of the isolates revealed two plasmids almost identical to 
pXO1 and pXO2 and also showed that the sequenced isolate was one of the 
most closely related to B. anthracis ever described (Klee et al., 2010). 
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Figure 1. Phylogenomic overview matrix created in Gegenees showing the average genomic core 
similarities between genomes. Final scores were calculated using a threshold value of 20 % for 
the normalized BLAST-scores to exclude genetic material not included in the core genome. Green 
represents a high similarity and yellow/orange represents a lower similarity. 
The majority of the Bacillus spp. genomes in the genome databases are 
pathogenic strains of which many represent these close-neighbor strains 
(Ehling-Schulz & Messelhausser, 2013; Segerman, 2012). This means that 
much has been divulged on the genomic similarities of the B. cereus group. 
However, there are still most likely many more variants of anthrax-like 
bacteria in the environment that we know nothing about. These closely related 
bacteria can cause molecular anthrax-diagnostics to fail or produce ambiguous 
results because of the similarity of the genomes. This is especially a problem 
when analyzing environmental samples such as soil (Kuske et al., 2006; 
Marston et al., 2006) and the molecular assays used must be as specific for B. 
anthracis as possible. 
1.1.2 Penicillin resistance 
Bacillus anthracis is considered susceptible to beta-lactam antibiotics such as 
penicillin but a few contradictory findings have been made. In 1947, Barnes et 
al. showed that the bacterium could produce penicillinase (Barnes, 1947). In 
2004, Athamna et al. showed that B. anthracis could be made resistant to a 
variety of antibiotics (e.g., ciprofloxacin, penicillin G and tetracycline) in vitro 
and suggested that monitoring of resistance in clinical cases should be made 
mandatory (Athamna et al., 2004). Fortunately though, reports of resistant 
isolates from fresh clinical samples are rare and one review article states that 
the total number of reported isolates was only five by 2004 (Turnbull et al., 
2004). 
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It has been shown that B. anthracis has two beta-lactamase genes but that 
their transcription is very low and was not induced by beta-lactam presence 
(Chen et al., 2003). The transcription of the beta-lactamases was shown to be 
controlled by an extracytoplasmic sigma factor (ECF) SigP and its anti-sigma 
factor RsiP (Ross et al., 2009) and it was further shown that this beta-lactam 
feedback system is non-functioning in prototypical B. anthracis-isolates. 
However, in a penicillin resistant strain, the rsiP gene was nonsense mutated 
and the strain constitutively produced beta-lactamases (Ross et al., 2009). 
During a Swedish anthrax outbreak in cattle in 2011, several resistant 
clones were isolated from different animals that succumbed to the disease 
during or after penicillin treatment (Paper IV). Due to its low cost and 
availability, penicillin is the recommended treatment of animal anthrax (WHO, 
2008) and it should probably stay that way due to its success in curing the 
disease in many outbreaks for many years. But an in-depth genomic analysis of 
these resistant isolates is still motivated to gain understanding into how 
resistance can arise. 
1.1.3 Life cycle and pathogenesis 
The bacterium spends the majority of its life as a dormant endospore in the 
soil. Exactly how an animal contracts the disease is not fully understood but 
ingestion and also inhalation of spores are considered the most likely routes of 
infection in animals (WHO, 2008). Insects have also been incriminated as 
being a vector for the disease (Fasanella et al., 2013b; Braack & De Vos, 1990; 
Turell & Knudson, 1987). In an animal model it has been shown that when 
spores enter the host they are phagocytosed by macrophages, but instead of 
being lysed they germinate inside the macrophage to their vegetative state 
(Guidi-Rontani et al., 1999). They then multiply in the lymphatic system 
followed by their release into the bloodstream, and as many as 10
7
 to 10
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organisms per milliliter of blood can be present in the late stages of the disease 
(Dixon et al., 1999). The pXO2-encoded capsule substance is here essential for 
evading phagocytosis of the vegetative B. anthracis cells (Drysdale et al., 
2005). The pXO1 plasmid is responsible for a tripartite exotoxin system 
consisting of 1) an edema factor that causes severe edema, 2) a lethal factor 
that causes necrosis of tissue and 3) a protective antigen that couples with 
either of the two toxin factors to produce one of the two binary active toxins 
(Young & Collier, 2007). The toxemia leads to systemic shock and death 
(Dixon et al., 1999). Due to scavenging or terminal hemorrhaging, blood can 
pour out of the animal after death (Bellan et al., 2013; Shafazand et al., 1999). 
When bacteria in the blood come into contact with free oxygen, they start to 
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sporulate again (Hugh-Jones & Blackburn, 2009) and complete the bacterium’s 
life cycle. 
1.1.4 Biosafety and anthrax in humans 
Anthrax is a zoonotic disease, i.e., it can be transmitted between animals and 
humans. However, it is primarily a disease of herbivores. Human infections are 
rare and the major sources are contact with infected animals and working with 
contaminated animal products (WHO, 2008). Bacillus anthracis is classified as 
a risk group 3 organism because of its pathogenic properties and work with this 
organism must be conducted under biosafety level 3 (BSL-3) conditions 
(AFS.2005:1) due to the risks involved. Some Swedish requirements for BSL-3 
work are: restricted entry to the lab and only via an airlock, separate HEPA-
filtered ventilation with negative pressure, solid and liquid waste must be 
autoclaved or, in another approved way, decontaminated before leaving the 
laboratory and all work with infected material must take place in a biological 
safety cabinet class I or II. Personal protective equipment according to risk 
assessment must be used and in the case of Bacillus anthracis full protective 
clothing including breathing protection must be used. Figure 2 shows work 
inside a class II biological safety cabinet in the BSL-3 laboratory and the 
personnel is wearing the protective clothing and an over-pressure respirator 
commonly used in BSL-3 laboratories. 
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Figure 2. Laboratory work inside a BSL-3 facility (Photo: Anna Sollén/SVA) 
Laboratory-acquired infections have been reported (Pike et al., 1965) and 
even under modern laboratory standards, infections have occurred (CDC, 
2002).  
There are three different well-known manifestations of human anthrax 
disease and a fourth one recently discovered. The cutaneous form is the most 
common one, in which spores come in contact with a lesion in the skin (Pile et 
al., 1998). Black necrotic lesions are formed and the name anthrax comes from 
these black ulcers as ‘anthrax’ is derived from the Greek word for coal. The 
prognosis for cutaneous infections if treated with antibiotics is good  (Pile et 
al., 1998). The second form is gastrointestinal that arises from eating meat 
contaminated with B. anthracis spores. This is a rare type of infection and it is 
believed that the mortality rate without treatment is high (Pile et al., 1998). The 
most severe form of infection is caused by inhalation of spores into the lungs. 
The infectious dose is relatively high with an estimated median lethal dose 
(LD50) of 2,500-55,000 spores (Inglesby et al., 2002). Historically, the fatality 
rate has been reported to be around 92 %, but during the anthrax terrorism 
attack in 2001 the rate was instead 45 % (Holty et al., 2006). The difference 
stems from advances in health care where rapid diagnosis leads to treatment in 
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the earlier phases of the disease. If the disease progresses to the fulminant 
septic phase, the mortality, as determined from case reports, is 97 % regardless 
of treatment (Holty et al., 2006). In the last ten years in Europe there have been 
several cases of a new form of anthrax referred to as injectional anthrax 
(Ramsay et al., 2010; Ringertz et al., 2000). The form has been seen among 
heroin addicts who have injected heroin contaminated with B. anthracis spores. 
This form has an estimated mortality rate of over 30 % (Grunow et al., 2013). 
1.1.5 Biological warfare and bioterrorism 
A 1993 report predicted that the release of 100 kg of anthrax spores upwind of 
Washington, D.C. from a single airplane would result in the death of 130,000 
to 3 million humans (U.S. Congress, 1993). Bacillus anthracis is one of the 
four bacterial category A bioterrorism agents listed by the US Centers for 
Disease Control and Prevention. Category A agents are by definition easy to 
disseminate and/or easily transmitted person-to-person, result in high mortality 
rates, can cause public panic and require special action for public health 
preparedness (CDC, 2014). There is however, a discussion on whether non-
experts can actually produce “weapon-grade” spores of B. anthracis, i.e., of 
uniform particle size, low electrostatic charge etc., to optimize aerosolization 
(Inglesby et al., 2002). Bacillus anthracis is also specified as a select agent by 
the Animal and Plant Health Inspection Service (APHIS) of the Unites States 
Department of Agriculture due to its risk to animal health (US Department of 
Agriculture, 2014).  
Although not believed to have an antagonistic cause, the outbreak of foot-
and-mouth disease in the UK in 2001 has been estimated to have cost £2.4–4.1 
billion (Kao, 2002) and has highlighted the impact an agricultural disease can 
have on society. Since anthrax is primarily an animal disease, there is of course 
a risk of a terrorist attack targeting animals instead of humans. Since many 
animals are more susceptible to the disease than humans are, the spores used in 
an animal attack would probably not have to be prepared to the weapon-grade 
form needed for a successful attack against humans. 
During World War I, B. anthracis was weaponized when vials containing 
spores had been placed inside sugar lumps for potential use against animals 
(Redmond et al., 1998). Since the 1940’s, B. anthracis has been used in the 
biological warfare programs of UK, US and the Soviet Union (Inglesby et al., 
2002). In 1942-43, aerosolization of anthrax spores with explosive devices was 
tested on the island of Gruinard in Scotland. Animals placed on the island, as 
an indicator of a successful aerosolization, did die of anthrax and the spores 
persisted in the soil for four decades until the island was finally 
decontaminated using formaldehyde (Manchee et al., 1994). 
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Three major anthrax-incidences have been described and they emphasize 
the risk of aerosolized spores. In 1979, there was an outbreak of inhalational 
anthrax in Sverdlovsk (former Soviet Union) due to an accidental release of 
spores from a military facility. Ninety-six people were reported to be infected 
and 64 died. The victims worked or lived in the wind direction from the 
facility. In the same direction, up to 50 km from the facility, animals also 
contracted anthrax (Meselson et al., 1994). A large-scale anthrax attack was 
performed in July 1993 when the religious group Aum Shinrikyo aerosolized 
B. anthracis spores from the roof of an eight-story building in Tokyo, Japan. 
Although successful in aerosolization of viable spores, they had used the 
Sterne 34F2 strain, which is used in Japan for animal vaccination (Takahashi et 
al., 2004). The strain lacks the pXO2 plasmid and no human cases were 
reported. The most famous bioterrorism incident is the anthrax letter attack in 
the USA in 2001. The letters contained fully virulent anthrax spores and were 
sent to news media offices and to two senators. The result of this terrorist 
action was 11 cases of cutaneous anthrax and 11 cases of inhalational anthrax 
and 5 of these cases were fatal (Jernigan et al., 2002). 
The incidence with the deliberate spread of anthrax in the US has raised the 
question of the possible use of anthrax for agroterrorism and APHIS has 
created a template for early-responders. The template is based on 
approximately 20 ecological and epizootiological criteria that can assist in the 
differentiation of a natural outbreak to a non-natural outbreak (US Department 
of Agriculture, 2007). 
The history of anthrax, and especially the anthrax letters, resulted in a fear-
potential that can have implications when handling a natural animal outbreak. 
However, it should be stressed that the massive amount of purified spores 
released in an antagonistic scenario and the high risk of infection in humans 
that follows is an extreme situation. It resembles nothing that can happen 
during a natural animal case (WHO, 2008). 
1.2 Outbreaks and disease control 
Anthrax is a notifiable disease under the Swedish Epizootic Act 
(SFS.1999:657, 1999), which means that any suspicion and/or occurrence of 
the disease must be reported to the Swedish veterinary authorities. Anthrax is 
also included in the disease list created by the World Organisation for Animal 
Health (OIE), which means that under the OIE Terrestrial Animal Health Code 
occurrences must be reported to the OIE (OIE, 2013). 
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Disease control 
The following brief summary on disease control of anthrax is based on the 
recommendations from the WHO (WHO, 2008) and also on how the Swedish 
anthrax cases in 2008, 2011 and 2013 were handled. 
After the diagnosis has been confirmed the remaining animals in the herd 
should as soon as possible be moved from the area of the first incident and be 
kept under strict observation. The first area should then as quickly as possible 
be decontaminated to prevent spread to wildlife. The area should also be placed 
under visiting restrictions and people and machines leaving the area should be 
properly decontaminated. If no other animals are showing symptoms there is a 
chance of the index case being an isolated infection and in this case a 
vaccination of the remaining animals can be performed. However, if more 
animals are showing symptoms or are dying, it is likely that many animals 
might have been infected and the disease progression should be halted by the 
use of penicillin. This will most likely save the majority of animals and if some 
animals still die from the toxins, the bacterial load has still been reduced and 
the carcasses will not contribute to further spread or contaminations (WHO, 
2008). Culling of the remaining animals was performed during the 2008-
outbreak due to practical issues of the decontamination of the farm and 
subsequent destruction (Lewerin et al., 2010). If it is possible to avoid, culling 
is not necessary as anthrax is not a chronic infection and the animals usually 
respond well to penicillin treatment. 
Anthrax worldwide 
In Europe and in parts of North America, sporadic outbreaks can follow the 
disturbance of old anthrax epizootic graves, such as at the creation of a ditch or 
a road (WHO, 2008). In some Mediterranean countries like Italy (Garofolo et 
al., 2011; Garofolo et al., 2010) and Turkey (Durmaz et al., 2012) there are 
endemic areas in which cattle, humans and wild animals have been infected. In 
Canada, there have been several reports on anthrax in wild Bison (Shury et al., 
2009; Nishi et al., 2007). In Texas there is an area with almost enzootic anthrax 
in white-tailed deer (Blackburn & Goodin, 2013). In several Asian countries 
the disease is still a large problem and in Cambodia and Vietnam it is even 
considered enzootic. In Africa, outbreaks occur in national parks e.g., in South 
Africa, Botswana, Namibia and Uganda. The situation is considered 
hyperendemic in Zambia and Zimbabwe (WHO, 2008). 
Anthrax outbreaks in Sweden 
In the first half of the 20
th
 century, anthrax outbreaks were common in Sweden 
with up to hundreds of reported outbreaks per year. One cause of these 
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outbreaks was shown to be imported contaminated meat-and-bone meal 
(Rutqvist L, 1957). In a study performed by the Swedish National Veterinary 
Institute (SVA), old records of anthrax cases between 1916 and 1961 were 
reviewed and summarized (Elvander, 2011). Over 3000 farms were identified, 
but the exact locations of the graves were not disclosed in these old records. 
However, the fact that a certain farm has had anthrax in the past can be of use 
in outbreak investigations. 
In 1981 there was a confirmed case of anthrax at a farm in the northern part 
of the province of Uppland. During the following 27 years, samples were sent 
to SVA, especially in summer-time, but no sample tested positive. The 
outbreak in 2008 was unexpected and without classical clinical signs it was not 
suspected to be anthrax at first. The outbreak in 2011 was more efficiently 
dealt with after method developments and lessons learned from 2008. 
The three latest outbreaks in Sweden are described below as they were the 
incitement of this thesis and they also provided good opportunities to evaluate 
developed methods. 
1.2.1  Veddige, province of Halland 2008 
The anthrax outbreak in 2008 occurred in a cattle herd with about 90 animals. 
The first seven dead animals had shown no clinical signs of anthrax except for 
fever. Eventually, at necropsy of three new dead animals, anthrax was 
suspected and the diagnosis could be made by cultivation and real-time 
polymerase chain reaction (PCR) (Lewerin et al., 2010). This outbreak 
occurred during winter-time and the animals were stabled and given feed in the 
form of roughage, which suggested that the feed was the carrier of the spores. 
An investigation was started where feed- and environment samples were 
collected in and around the barn and also at locations where the feed had been 
harvested. The samples were analyzed with methods that were not validated for 
finding a low number of spores in large amounts of matrix. No samples gave 
positive results and the source of the outbreak has not been determined. The 
theory that the feed was the source is supported by the extreme drought the 
previous summer that had enabled harvesting of feed at a previously 
unavailable, flooded, area. The area laid next to the bank of a big river that 
people, allegedly, dumped dead animals into during the early 1900’s (Lewerin 
et al., 2010). The economic consequences of the outbreak were substantial as 
60 million SEK was put into the sanitation of the farm. One report states that 
the high costs might have been due to an overestimation of the risks involved 
(Knutsson et al., 2012). 
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1.2.2  Kvismaren nature reserve 2011 and 2013 
In the summer of 2011 an outbreak in cattle occurred in a nature reserve called 
Kvismaren not far from the city of Örebro. Poisoning with cowbane (Cicuta 
virosa) was first suspected when grazing cattle abruptly died on a large pasture. 
However, when anthrax was confirmed the remaining cattle were moved to 
another area and treated with penicillin. As more animals died, a second 
treatment with antibiotics was started using procaine penicillin. Despite this, 
some fetuses were aborted. A total of 24 animals died and three fetuses were 
aborted. Bacillus anthracis isolated from animals and fetuses that died despite 
treatment were all confirmed resistant to penicillin by minimum inhibitory 
concentration (MIC)-tests. 
The source of the outbreak was suspected to be an anthrax epizootic grave 
from 1943 (Elvander, 2011). Ditch-clearing had been performed in the spring 
2011, which was suspected to have released spores from the old anthrax grave. 
A complication during the outbreak was that the spores were spread via the 
large ditches and the large Kvismare canal to a nearby pasture where yet 
another animal died. Soil-, sediment- and water samples were analyzed using 
PCR-analysis, which indicated where contamination was present and action 
was taken to prevent further disease from this source. All remaining animals 
were vaccinated and were allowed to return to the outbreak area the following 
year. 
Surprisingly, in 2013, a heifer died of anthrax on a farm not far from the 
2011-outbreak. How the anthrax spores got there could not be explained as 
water flows in the opposite direction and the animals had no other interaction 
with the area contaminated in 2011. Wildlife seems to be the only reasonable 
explanation for the spread to this new area. All remaining animals were 
vaccinated. The 2013-isolate was whole-genome sequenced and found to be 
nearly identical with the 2011-isolates as it showed only 3 unique 
chromosomal base pair mutations (unpublished). 
1.3 Diagnostic methods 
There are many methods published on detection and identification of B. 
anthracis, but in this thesis only the methods commonly used in diagnostic labs 
in Sweden will be discussed. They comprise the classical bacteriology, e.g., 
cultivation and microscopy coupled with DNA-extraction and real-time PCR. 
Genotyping methods are also discussed as they are important for inferring 
relationships between strains. 
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1.3.1 Bacteriology 
Bacillus anthracis is readily isolated from, for instance, a fresh blood sample 
as it grows very well on blood agar. The colonies are large, white, non-
hemolytic and irregular. Colonies on a horse-blood agar plate are shown in 
Figure 3. 
 
 
Figure 3. Colonies of B. anthracis strain SVA11, from the outbreak of 2011, on a blood-agar 
plate. The insert shows a single colony of the same strain. 
The Gram-positive rods can, under the microscope, be seen as long chains 
of cells. This is more often seen from in vitro cultivated material as the chains 
are often not as long from fresh clinical material (WHO, 2008). If cultivated 
under elevated CO2-levels and on bicarbonate-serum agar the bacterium 
produces its capsule substance (Meynell & Meynell, 1964). The capsule can be 
stained using McFadyean’s polychrome methylene blue staining and viewed 
under microscope (Spencer, 2003) but the change in colony morphology alone 
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may also be indicative enough. Separating B. anthracis from other closely 
related Bacillus spp. is not always trivial but there are some classical 
distinguishing traits that when put together should differentiate it from the 
other species. They include i) colony morphology ii) no hemolysis and no 
motility iii) sensitivity to the ‘gamma’ phage and penicillin iv) capsule 
formation (WHO, 2008). However, in unusual cases, a close-neighbor strain 
might be indistinguishable from B. anthracis using phenotypical traits 
(Marston et al., 2006) and a combination of traditional bacteriology and 
molecular methods is therefore preferably used. 
Isolation of an outbreak strain is of highest importance as a pure isolate is 
required for whole-genome sequencing, antimicrobial susceptibility testing and 
other follow-up analyses. Isolating the outbreak strain is preferably done from 
fresh animal blood samples. However, in order to connect a potential source to 
a clinical case, isolation of the strain from the potential source is required. 
Cultivating the bacteria from soil- or environmental samples can be difficult 
due to the background flora in them. In these cases, cultivation on semi-
selective medium and/or treatments with heat or ethanol should be attempted. 
Since spores are resilient to heat and ethanol, the background flora can be 
decreased using either one of the treatments before plating the sample (Dragon 
& Rennie, 2001). This would enable growth from samples containing anthrax 
spores and various vegetative bacteria since theoretically only the spores would 
survive. However, soil samples will most likely contain other spore-forming 
Bacillus-species, which also can survive the pre-treatments. 
 The polymyxin, lysozyme, ethylenediaminetetraacetic acid, thallous acetate 
(PLET) agar has since its development in 1966 (Knisely, 1966) been of great 
use. It is regarded to be semi-selective as some other Bacillus spp. have been 
shown to grow on PLET (Marston et al., 2008; Dragon & Rennie, 2001). 
Dragon et al. saw indications that not all of the B. anthracis spores added to the 
PLET-agar plate germinated which can be detrimental to recovery from 
samples with a low number of spores (Dragon & Rennie, 2001). The PLET-
agar has recently been modified by Luna et al. by adding trimethoprim and 
sulfamethoxazole to further enhance its selectivity for B. anthracis (Luna et al., 
2009). An isolation method called Ground Anthrax Bacillus Refined Isolation 
(GABRI) has shown good results as it effectively reduced the number of non-
anthrax bacteria in the sample (Fasanella et al., 2013a). The method employs 
washing of relatively large soil samples followed by centrifugation to pellet 
sample debris. The supernatant is then heat-treated, subjected to fosfomycin 
and then plated on a semi-selective medium similar to PLET. GABRI was also 
tested, with success, on naturally contaminated soil samples from an outbreak 
area in Bangladesh Fasanella (Fasanella et al., 2013a). 
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1.3.2 DNA-extraction and PCR 
Molecular detection of B. anthracis is advantageous as the bacteria do not need 
to be viable, in contrast to the cultivation analyses. In some cases this strength 
is also a weakness as no information is given on viability of the bacteria in the 
sample. Cultivation and molecular methods should be used as complements to 
each other as no method answers all the questions. As an example, an animal 
that has been dead for some time usually does not contain viable bacteria so 
PCR is needed to confirm anthrax. However, the spores around a carcass are 
probably easier to find using selective cultivation media. 
The difficult part of molecular detection of B. anthracis is that the bacteria 
form endospores, which are very difficult to extract DNA from. Spores are 
resilient to many lysis buffers and chemicals as well as to heat and mechanical 
force (Nicholson et al., 2000). Spores that have germinated into its vegetative 
state are easier to lyse using lysis buffers but the germination step would of 
course increase the analysis time. Germination of spores occurs when nutrients 
(e.g., broth) are added to the sample and the spores come in contact with 
certain molecules (e.g., L-alanine and Inosine) that trigger germination (Fisher 
& Hanna, 2005). Enrichment is one way of increasing both the chance of 
extracting DNA from the bacterium (since it is no longer a spore) and also the 
number of bacteria to extract DNA from (since the bacteria have multiplied). 
Enrichment overnight in PLET-broth significantly improved DNA extraction 
and detection from B. anthracis spores in soil (Gulledge et al., 2010). 
Enrichment for 3-4 hours in brain-heart infusion broth has showed good results 
in subsequent DNA-extraction and PCR with detection levels down to 10 
viable spores/0.25 g of soil (Ågren, unpublished).  
A direct DNA extraction from a sample can be attempted when analysis 
time is of utmost importance. Wielinga et al. spiked feed and food matrices 
with B. anthracis spores and used a kit that contains guanidine thiocyanate as 
lysating substance, which had earlier shown good results (Wielinga et al., 
2011a; Dauphin et al., 2009). The study evaluated the viability of two different 
Bacillus-strains after lysis buffer treatment with different concentrations of 
lysis buffer, and it showed that a fraction (15-30 %) of the spores survived lysis 
treatment. The study also took into account the adaptations and optimizations 
that were needed to use a kit or protocol inside a BSL-3 laboratory. This is 
often overlooked or not mentioned in reports on DNA-extraction. Another 
finding was that the different matrices tested produced different levels of 
DNA-recoveries and subsequent PCR-inhibition (Wielinga et al., 2011a). 
There are several commercially available DNA-extraction kits and they 
typically contain some kind of lysis buffer that, sometimes in conjunction with 
mechanical force, lyses the cells. Silica columns, magnetic beads or DNA-
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precipitation are often used to purify the DNA from the remaining sample. A 
recent comparison of nine commercial kits showed that the choice of kit is 
crucial as there were large differences in DNA-extraction efficiencies (Thomas 
et al., 2013). For automation and higher sample throughput the use of DNA 
extraction robots has become the standard way of extracting DNA for many 
pathogens. The Qiagen EZ1 (Qiagen, Hilden, Germany) for instance has been 
extensively used at SVA for DNA-extraction of B. anthracis from blood and 
tissue samples. However, soil, feed and environmental samples are often 
analyzed for anthrax outbreak investigations and then DNA could be extracted 
using an automated solution but there would be a need for some kind of pre-
treatment. Straws of hay, soil particles, small rocks etc. are components in 
these samples that cannot go into the automated DNA extraction robots for 
obvious reasons. Manual kits and/or several pre-treatment steps are needed for 
such samples due to their complexity. These sample matrices can give rise to 
problems for the extraction kits and can contain inhibitors that also inhibit the 
PCR analysis of the extracted DNA. The inhibition comes mostly from organic 
substances that are co-extracted with the DNA such as humic substances from 
soil that are strong PCR inhibitors (Tebbe & Vahjen, 1993). The method used 
for DNA-extraction must both be efficient at extracting DNA but also at 
purifying the DNA so that inhibitor substances are washed away. 
Once the DNA has been extracted from the sample, the PCR is the most 
commonly used DNA-detection method. A problem in B. anthracis detection 
by PCR is that the close-neighbor strains (described under 1.1.1) can contain 
DNA-sequences that are identical, or almost identical. This can enable 
amplification of DNA although no B. anthracis bacteria were present in the 
sample. A thorough primer design and PCR optimization is therefore of 
greatest importance. 
1.3.3 Molecular genotyping 
Molecular strain characterization, so called genotyping, is used to determine 
how a strain is genetically related to other strains. Bacillus anthracis is one of 
the most clonal species known, meaning there is extremely little genetic 
heterogeneity between strains found all over the world (Van Ert et al., 2007). 
This clonality makes molecular typing difficult and high-resolution 
technologies are needed to separate the strains from each other (Keim et al., 
2004). 
A technique that has been widely used since its introduction in 2000 is the 
multiple locus variable-number tandem repeat analysis (MLVA) for B. 
anthracis, which basically measures the amount of repeats in eight repetitive 
regions in the genome (Keim et al., 2000). This method has been extended in 
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steps from the 8 loci looked at in 2000 to 31 loci in 2012 (Beyer et al., 2012). 
A variant of a variable-number tandem repeat (VNTR) is the single nucleotide 
repeats (SNR) which possesses an extreme variability thus being suitable for 
studies looking at a short time frame (Derzelle & Thierry, 2013). VNTR and 
SNR loci diverge faster than the rest of the genome due to their proneness to 
accumulate errors during replication (Keim et al., 2004), but they are also 
subject to reversals and homoplasy, which sometimes limit their phylogenetic 
values (Derzelle & Thierry, 2013). For elucidating deeper phylogenetic 
relationships, single nucleotide polymorphisms (SNPs) are very stable over 
time (Keim et al., 2004). SNPs are single base mutations that can occur at most 
base positions in the genome and they are not prone to homoplasy, which 
makes their phylogenetic value high (Pearson, 2004). Van Ert et al. developed 
a genotyping scheme based on a set of so-called canonical SNPs (canSNPs) 
using more than 1000 isolates (Van Ert et al., 2007). These twelve canonical 
SNPs represent the big evolutionary lineages for B. anthracis and can replace a 
genome-wide SNP analysis when placing a new isolate phylogenetically. If 
strains of different canSNP-types cause outbreaks the canSNPs method could 
separate the outbreak strains. However, the canSNPs are evolutionary markers 
and they might not be useful for epidemiological analyses during a single 
outbreak (not even if the outbreak occur over an extended period of time). In 
these cases, either MLVA or a whole genome sequencing approach with 
genome-wide SNP-analysis (Kuroda et al., 2010) could be performed to find 
the few mutations acquired during this short time frame. 
It should also be noted that since anthrax is not commonly transmitted 
animal-to-animal, epidemiological studies on anthrax outbreaks are more 
focused towards finding a source for the outbreak or a point of introduction. 
Determining a genotype can say something about the origin of an outbreak 
strain (Grunow et al., 2013; Price et al., 2012), whether it may come from a 
laboratory (Hoffmaster et al., 2002) or if it is commonly found in an area of 
previous natural outbreaks (Fasanella et al., 2005; Fouet et al., 2002). 
1.4 Genomics and next-generation sequencing 
The genome of an organism refers to the total amount of DNA within that 
organism. In genetics, one or several genes are studied whereas in genomics 
the whole genome is studied. This includes comparative genomics where 
genomes from several organisms are compared to each other. Technologies 
used in genomic studies include whole-genome sequencing (WGS) and 
assembly of the DNA-sequence to facilitate further genomic analysis. To have 
the genome-sequence of a pathogen can answer many questions e.g., why a 
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strain has become resistant to an antimicrobial substance (Ågren et al., 2014), 
why a strain is extremely pathogenic and causes severe complications 
(Mellmann et al., 2011) or how to find biomarkers for a new emerging 
pathogen (Hoffmann et al., 2012). Genomic studies have been the basis for the 
results of this thesis and some background to that field is presented here. 
When sequencing DNA, a sequencing technology is used to ‘read’ the 
sequence of A, C, T and G of a small part of the DNA, usually some hundred 
base pairs (bp). The most commonly used method has been the chain-
terminating approach developed by Sanger et al. in 1977 (Sanger et al., 1977). 
This technology has been further developed and has been used to sequence 
whole genomes of organisms. The sequence gathered using Sanger sequencing 
can be up to 900 bp long (Liu et al., 2012). The first bacterial genome to be 
fully sequenced was that of Haemophilus influenza in 1995 (Fleischmann et 
al., 1995). The first complete genome sequence of B. anthracis was published 
in 2003 by Read et al. and it was sequenced using Sanger sequencing (Read et 
al., 2003). This was both costly and time-consuming as the sequencing work 
took 18 months and the genome finishing (see below) work took over 2 years 
(Bergman, 2011). 
The advent of different next-generation sequencing (NGS) technologies has 
revolutionized the way DNA is sequenced. Their common denominator is that 
they sequence numerous randomly located DNA-sequences at the same time 
(i.e., parallel sequencing), up to billions of sequences simultaneously (Liu et 
al., 2012). Each sequence gathered is called a ‘read’ and is usually some 
hundred bp long for NGS (Quail et al., 2012) although the NGS technology by 
Pacific Biosciences has produced average read lengths of over 4,000 bp and 
maximum read lengths of 27 kb (Koren et al., 2013). 
The B. anthracis genome is 5.4 million bp (Read et al., 2003), which means 
that 6,000 of 900-bp Sanger-reads are needed to sequence the whole genome to 
a genome-coverage of 1x. However, in a shotgun approach with random 
sequence start points, to create several overlapping reads with several different 
starting points, a high coverage of sequencing reads is needed. Overlapping 
reads, that are covering a longer stretch of DNA, can be put together to create 
long, so called, contigs of DNA sequence. Putting short DNA-reads together to 
form longer contigs is called assembling. If there are no reads covering an area, 
or if there is uncertainty as to where the reads should be (usually because of 
repetitiveness), the contig cannot be elongated further and a gap is formed. If 
all of these gaps have been solved and genome finishing work has ensured that 
the single contig left is the correct DNA-sequence, it is called a ‘complete 
genome’ sequence. If the sequence has some gaps left or there are possible 
misassemblies or poorly covered areas, it is called a ‘draft genome’. An 
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illustration of how sequence reads are assembled into longer sequences is 
shown in Figure 4. 
 
 
Figure 4. Overview of the sequence assembly, from sequence reads to the finished genome. A) 
DNA sequence reads from the sequencing machine. B) Assembled contigs. The assembly of reads 
is done by assembly software that tries to elongate the consensus sequence as long as possible. 
See inserted example. A high coverage generally gives a better assembly with higher accuracy. C) 
Genome finishing work requires hands-on work as the contigs must be elongated manually as far 
as possible to get them to overlap. The use of extra Sanger-sequencing might be needed. Paired-
end read and/or mate-pair read information (red-and-black read) can be used to determine order of 
contigs. D) The finished genome sequence that should accurately depict the original genome 
sequence. 
NGS has opened up new areas of research and also the speed at which 
researchers can obtain genomic DNA sequence data. Bacteria and viruses can 
be sequenced during the disease outbreak they are causing (Baize et al., 2014; 
Köser et al., 2012) and investigations of a pathogen’s origin or transmission 
history can be performed with high resolution (Harris et al., 2013). Publically 
available sequence databases contain these growing numbers of DNA-
sequences and this creates valuable reference data. Good reference databases 
with sequences together with high-quality metadata (e.g., epidemiological data 
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such as geographical location of a confirmed disease outbreak together with 
information about time of isolation of outbreak strain) are essential for 
investigations on pathogen outbreaks as the pathogen can then be related to 
previous outbreaks or other sequenced pathogens (Sjödin et al., 2013). 
In 2011, NGS machines were released from Life Technologies and Illumina 
(IonTorrent PGM and the MiSeq) that had lower output than the previously 
available machines but came at a lower cost and had faster turnaround times 
(Quail et al., 2012). Where the larger machines (e.g., Illumina HiSeq 2000) are 
aimed at large scale sequencing producing facilities and at large eukaryote 
genome sequencing projects, these smaller machines are more suited for rapid 
local sequencing of small bacterial genomes. As they are fast and do not 
require a specialized core-facility they are suitable for bacterial or viral 
outbreak investigations (Quail et al., 2012). 
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2 Aims of the thesis 
The overall aim of this project was to facilitate the handling of anthrax 
outbreaks by genomic studies and improved diagnostics. More specifically, the 
aims were: 
 
 To investigate whether genetically close Bacillus-species could mimic 
B. anthracis-spores phenotypically and thus be used as a model system 
for anthrax spores. The model system could be used in developing 
diagnostic methods and be a simulant in realistic exercises. 
 
 To develop methodology for comparing several hundreds of bacterial 
genomes to each other on a normal workstation computer. If this would 
be possible the genomic characterization of an outbreak pathogen’s 
genome would give genomic support to real-time epidemiological 
investigations. 
 
 To evaluate the capacity of the developed methodology (bullet point 
above) to predict PCR-cross reactions in silico. 
 
 To investigate how the antibiotic resistance arose during an anthrax 
outbreak in 2011 and also if this has implications for the current 
treatment procedures. 
 
 To investigate what support whole-genome sequencing could bring to an 
epidemiological investigation. 
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3 Comments on materials and methods 
3.1 Spore hydrophobicity 
An important phenotypic trait that is important for extracting a spore from a 
sample matrix is the hydrophobicity of the spore. It determines which buffers 
should be chosen and how the spore will behave in different environments. A 
commonly used technique to determine the hydrophobicity is the microbial 
adhesion to hydrocarbon (MATH) test, which was developed in 1980 
(Rosenberg et al., 1980). Although slight modifications of the method have 
been reported, it is based on the separation of cells or spores between an 
aqueous phase and a hydrocarbon phase. Briefly, the MATH-assay is 
commonly performed in glass vials where the spores in the aqueous phase are 
mixed or vortexed with the hydrocarbon phase. After a settling time the 
absorbance of the aqueous phase is measured and compared with its original 
absorbance value. 
Although the MATH-assay was originally supposed to be included in Paper 
I there are no hydrophobicity results reported and there are several reasons for 
this. Inside the BSL-3 facility glass tubes or vials were not allowed, due to risk 
of breakage. Several different plastic tubes were evaluated but they all 
produced ambiguous results with little or no reproducibility. The spores 
seemed to adhere to the surface of the plastic tubes, which was somewhat 
remedied by using Protein LoBind tubes (Eppendorf) but reproducible results 
were still not achievable. 
Other studies have reported different setbacks of the method. One research 
group found that microdroplets of hexadecane were formed that interfered with 
the absorbance measuring (Zoueki et al., 2010). This is in accordance with a 
paper by Leishman et al. where the recovery of the spores from the hexadecane 
phase was not correlated to the change in absorbance. In that paper it was also 
stated that heating of the spores, the amount of hexadecane, the mixing times, 
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the settling times and also strain-dependant sedimentation rates could interfere 
with the final MATH-results (Leishman et al., 2010). 
3.2 Whole genome sequencing 
For the initial assembly of the 2011-outbreak strain, the isolate from the first 
sample sent to SVA was chosen. DNA was prepared from an overnight culture 
using the MasterPure Gram positive kit (Epicentre Biotechnologies, Madison, 
WI, USA) and filtered through an Ultrafree-MC 0.22 µm sterile filter (Merck 
Millipore, Billerica, MA, USA). Sequencing on both the Roche 454 GS FLX+ 
and the Illumina HiSeq 2000 was performed by Science for Life Laboratory 
(Stockholm, Sweden). The 454-run used chemistry that enabled long read-
lengths and it produced an average genome coverage of 21x. The reason for 
using both Roche and Illumina techniques was to achieve long 454-reads for 
the initial assembly and using the shorter, more accurate, Illumina-reads for 
assembly-correction. The 454-technology suffers from poor sequencing 
accuracies across homopolymeric regions, which the Illumina-technology does 
not (Luo et al., 2012) making them a good complement. The Illumina-reads 
yielded a coverage of 112x and were used to correct several hundreds of 
mostly minor assembly errors. A few weakly resolved areas still remained and 
these were solved by Sanger sequencing. The remaining genomes were 
sequenced using an Illumina MiSeq with 2x250 bp paired-end reads and the 
reads were mapped to the finished outbreak genome. Differences were located 
using Consed/cross-match and MUMmer. 
For the RNA-sequencing the MiSeq was used but the input RNA was first 
depleted of ribosomal RNA before prepared for sequencing. The ribosomal 
RNA is the most abundant RNA and would make up the majority of the input 
material and the output reads if not removed. The RNA was sequenced using 
short 1x50 bp settings since the transcriptome was not to be determined but 
rather quantified. Reads were mapped to the coding regions of the genome 
using Bowtie2 with the most sensitive settings. The output of aligned reads was 
analyzed using the software Cufflinks and Cuffdiff 2. Since longer genes 
would get more “hits” when mapping the reads to the transcriptome, they are 
normalized and the transcript abundances are given as fragments per kilobase 
of exon per million fragments mapped (FPKM). Cuffdiff 2 tests each transcript 
for significant difference of abundance between two samples. 
The outbreak-isolate of 2013 was sequenced using the fastest possible 
methods to provide real-time support to the investigation. DNA from two 
colonies was extracted using the EZ1 Advanced (Qiagen), sterilized using 
Millipore Ultrafree-MC 0.22 µm sterile filter and taken from the BSL-3 
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laboratory. After concentration measurement, the DNA was prepared using the 
Nextera XT-kit (Illumina) and sequenced on a MiSeq using 1x50 bp settings. 
For quality assurance, the FastQC software (Andrews, 2010) analyzed the 
reads and, due to the short read length, the majority had quality values close to 
Q40. By aligning the reads using Bowtie2, the fraction of reads not aligned was 
determined to be less than 0.3 %. This showed that 99.7 % of the reads aligned 
perfectly to the outbreak genome of 2011. By mapping the reads to the 2011-
outbreak-genome using Consed/cross-match, the polymorphisms could be 
determined. 
3.3 Creation of the phylogenomic overviews in Figure 1 and 
Paper III 
To illustrate the genome similarities of the B. cereus group a few strains have 
been included in a phylogenomic overview created in Gegenees (Paper II), 
both in this thesis with fewer strains and as a table in Paper III. The genomes 
were compared using the accurate-setting of Gegenees and the phylogeny is 
based on score values with a threshold of 20 %. This means that the average 
BLASTN-scores of the core genomes are used, as genetic material not included 
in the core genome is sorted out with the threshold. 
In Paper III, we considered genomes of 80 % average core genome 
similarity to B. anthracis to be called near neighbors, as to our knowledge, no 
real definition of the close neighbor-concept exist. This might seem arbitrary 
but genomes of strains that have been called near neighbor or close-neighbor in 
the literature (although they are not all included in either of the illustrations) all 
pass this criterion. Strains with 80 % similarity or above are also part of one of 
the three main phylogenetic clusters of the B. cereus group population, along 
with B. anthracis (Kolsto et al., 2009). Strains with less than 80 % similarity in 
such a phylogenomic overview created in Gegenees are part of the other two 
clusters. In Figure 1 strains number 6 and 7 represent strains that are relatively 
closely related to B. anthracis but not as much as strains number 3, 4 and 5 and 
might not be traditionally viewed as close neighbors. 
3.4 Growth rate experiment 
A growth rate test was performed on one resistant isolate and one previously 
resistant that had acquired a counter-acting mutation. Five 1.5 ml micro tubes 
with 1.0 ml of Luria-Bertani medium were inoculated for each of the two 
variants of B. anthracis. The tubes were incubated at 37°C in a Thermomixer 
(Eppendorf) with a mixing frequency of 400 rpm. During five hours of 
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incubation, at every 20 minutes, the growth was measured by placing part of 
the medium in plastic cuvettes in a spectrophotometer and then transferred 
back to the micro tube. The growth rates were estimated by fitting exponential 
growth curves to the experimental data using non linear regression but no 
significant differences in growth rate were seen. 
Since these isolates with counter-acting mutations were clearly enriched 
somehow in our standard laboratory procedures (Paper IV) we suspected that 
the growth rate difference must be substantial but this growth test showed it 
was not. However, this study should be complemented with a more high-
resolution method such as controlled head-to-head competition (Elena & 
Lenski, 2003) to conclusively determine the fitness of the two variants of the 
strain. 
3.5 DNA-extraction from environmental samples 
During the outbreak investigation of 2011, over 200 soil- and sediment 
samples were processed and a DNA-extraction method was developed that 
produced robust extractions with little or no subsequent PCR-inhibition. A 
problem with direct DNA-extraction from such samples is that the spores are 
hard to lyse and that they are usually found in very low numbers (Dragon et al., 
2005; Manchee et al., 1994). Therefore a short enrichment step was evaluated 
as this would germinate the spores and increase their number slightly. 
Soils and sediments vary in physical characteristics and in composition 
which can affect the growth of certain bacteria (Ellis et al., 2003). This means 
that positive control spores should be added to each sample as there is no other 
way of determining the success of the enrichment and the subsequent DNA-
extraction. We solved this by using different model spores evaluated in Paper 
I. A possible problem with the B. cereus spores that mimicked B. anthracis 
spores the best, is that there is a slight risk of similar bacteria already being 
present in the soil sample. This had not been seen during development of the 
method where a variety of soils were tested, but the risk cannot be neglected. 
For the 2011-outbreak samples we used spores of B. thuringiensis var. kurstaki 
HD-1 that is commonly used as an insecticide. The crystal protein gene cry1 
found in B. thuringiensis strains was used as PCR-target. This control strain 
might be a poor choice if the samples come from an area where B. 
thuringiensis spores are used to decimate the mosquito population, e.g., around 
the Swedish river Dalälven where var. israelensis is used. Guidi et al. stated 
that B. thuringiensis spores could be found in very high numbers in an area that 
had been annually treated for mosquito control (Guidi et al., 2011). We made 
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no such findings during the 2011-outbreak and the area has most likely never 
been treated since it is a nature reserve. 
Briefly, 400 µl of brain-heart-infusion medium was added to roughly 0.25-
0.5 g of sample in a 1.5 ml micro tube, which was then inoculated with 40 
spores of B. thuringiensis var. kurstaki HD-1. The control spore stock 
consisted of circa 40 spores per 10 µl and stored in Protein LoBind-tubes 
(Eppendorf). The concentration was determined by plating once a week and the 
concentration was stable throughout the outbreak period. The sample was then 
incubated for four hours at 37°C with shaking in a thermomixer at 500 rpm, 
before extracted using a DNA-extraction kit. 
Evaluation of suitable soil-extraction kits was made and the SoilMaster™ 
DNA Extraction kit (Epicentre Biotechnologies, Madison, WI, USA) gave high 
DNA-yields, but together with high levels of PCR-inhibition as not even a 
hundredfold dilution of the extracted DNA could circumvent the inhibition. 
Instead, the PowerSoil® DNA Isolation Kit (MO BIO Laboratories, Inc., 
Carlsbad, CA, USA) was deemed the best solution as it included a bead-
beating step that could safely be used in the BSL-3 laboratory, and of the over 
200 soil- and sediment samples analyzed with it, only one showed PCR-
inhibition and that sample contained feces. 
PCR was then performed that detected targets in B. anthracis and in the 
spore control to ensure the enrichment and DNA-extraction had been 
successful. The method proved very stable as the PCR-results were basically 
identical for the control spores across all samples in that batch. A separate 
PCR-reaction was performed on the same extracted DNA in which unrelated 
DNA was added to monitor PCR-inhibition. Optimally, these two reactions 
should have been performed in the same tube with an internal inhibition 
control but it was found that when multiplexing using three or four targets, the 
sensitivity and efficiency of the B. anthracis PCR was lowered. 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
41 
4 Results and discussion 
4.1 A model system for B. anthracis-spores (I and II) 
Work with B. anthracis in Sweden is restricted to special BSL-3 facilities in 
which work is both time consuming and costly. In many countries, the BSL-3 
restriction is also true for attenuated strains, which lack one or both virulence 
plasmids. Surrogate or model strains of non-virulent species are therefore 
desired when developing new diagnostic methods or during exercises or 
trainings. 
Model strains for B. anthracis have been used frequently in studies in the 
past, and this has been reviewed by Greenberg et al. (Greenberg et al., 2010). 
However, the review showed that the majority of the studies had used B. 
atrophaeus (formerly B. globigii and B. subtilis var. niger), which is not 
closely related to B. anthracis (Gibbons et al., 2011; Xu & Cote, 2003). The 
benefit of using B. atrophaeus lies in its complete lack of pathogenicity, which 
enables large-scale aerosolization experiments and exercises (Edmonds et al., 
2009; Stratis-Cullum et al., 2003). 
In Paper I the assumption that spores of genetically related strains behaved 
similarly phenotypically was evaluated. A model system for B. anthracis 
spores was to be proposed that was intended to be used as model in detection 
studies in feed and food and in exercises. However, the model was not intended 
for aerosolization studies thus not having the non-pathogenicity demand since 
experiments could be carried out in normal BSL-2 laboratory settings. 
For the genetic analysis we used the sporulation stage III AB gene 
(spoIIIAB) to screen over 50 strains of Bacillus spp. as described by Ehling-
Schultz et al. (Ehling-Schulz et al., 2005). This method utilizes a single gene 
instead of the seven used for MLST, thus being cheaper to use but it still 
yielded the same tree topology. A whole genome sequence comparison was 
also performed for the strains with draft or completed genome sequences 
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deposited at Genbank, using the ASC method (Segerman et al., 2011). It was 
found that the clustering of the spoIIIAB phylogenetic tree was supported by 
the whole genome analysis (Paper I). 
Six Bacillus spp. from different clusters in the spoIIIAB analysis were 
chosen and were together with two B. anthracis strains sporulated and 
phenotypically analyzed. It was shown that the two B. cereus strains 
NVH0597-99 and F2085/98 were highly related to B. anthracis genotypically 
and they also showed the most similar phenotypical properties (Paper I). They 
showed similar heat-inactivation patterns, similar germination patterns and 
they even grew on the modified PLET agar, which is valuable for realistic 
exercises. 
The two model strains proposed are suitable if parameters like germination, 
growth or heat-deactivation are important in an experiment. Their close genetic 
relationship with B. anthracis suggests they are also suitable for other types of 
experiments but this would of course have to be evaluated first. When 
performing studies of heat deactivation or decontamination it might be wise to 
choose a more conservative, fail-safe model to introduce some margin of error. 
In our case this would be the B. thuringiensis strain, which showed a higher 
tolerance to heat than B. anthracis or the two suggested B. cereus models 
(Paper I). It should also be emphasized that the two model strains suggested 
are isolated from human infections and must only be handled in a BSL-2 
laboratory. 
A topic not discussed in Paper I is the ability to trace the model organisms 
in a complex experiment with perhaps several other Bacillus spp. in the sample 
matrix, e.g., a spiked soil sample. A solution to this problem has recently been 
proposed where genetic signatures, also called ‘barcodes’, were introduced into 
the chromosome of a B. thuringiensis subsp. kurstaki strain (Buckley et al., 
2012). The inserted barcodes then worked as targets for specific PCRs and the 
model organism could be traced in a mix of near-neighboring strains. The two 
strains we proposed as models have been whole genome sequenced; the 
NVH0597-99 is available from Genbank (NCBI Acc. no. ABDK00000000) 
and the F2085/98 genome has been sequenced at SVA to a draft state but not 
yet made publically available. Our solution to the tracing issue was to use the 
Gegenees software (Paper II) to compare the models’ genomes to all Bacillus-
genomes publically available, thus locating possibly unique signature 
sequences. Real-time PCRs were then designed to these regions, evaluated in 
vitro, and then used to trace the model in complex samples in different 
experiments (unpublished). 
Strains identified in Paper I have been successfully used during the Swedish 
anthrax outbreak of 2011 as controls for the DNA-extractions and detection by 
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PCR. This ensured a reliable interpretation of results from environmental 
samples. They have also been used in exercises and in several method 
developments. 
4.2 Characterization of a bacterial genome during an outbreak 
(II) 
When a bacterial disease outbreak occurs, the outbreak strain is often 
genotyped using MLST, MLVA or other genetic methods. This can provide 
information about the origin of the strain and if the pathogenic strain, or at least 
if a related strain, has been isolated and genotyped in the past. With the 
improvement of NGS technology and the large number of sequenced strains in 
reference databases, it is becoming more and more common to whole-genome 
sequence a pathogen and compare it to previously sequenced strains. However, 
the technological advancements in NGS have not been matched by analysis 
software that can handle the large amount of genomes. 
For this purpose, the software called Gegenees was created (Paper II). It 
can compare several hundred bacterial genomes on a normal workstation 
which, together with the graphical user interface, enables whole genome 
comparisons for a bigger community of researchers and clinicians. Whole 
genome alignment in the traditional sense is very computationally intensive 
and time-consuming. In Paper II it was shown that comparing 30 Bacillus- 
genomes in the software progressive Mauve (Darling et al., 2010) took almost 
70 hours and that no more than 30 genomes could be aligned due to memory 
error issues. Gegenees is highly scalable, which means that the amount of 
computer memory used stays at the same low level regardless of the number of 
genomes aligned. This is due to the fragmented approach where the genomes 
are fragmented into smaller pieces (usually 100-500 bp), which are then 
sequentially aligned to the whole genomes using Basic Local Alignment 
Search Tool (BLAST) (Camacho et al., 2009; Altschul et al., 1990). 
Although Gegenees uses alignments, it does not produce a traditional 
alignment file but instead produces conservation patterns. The default setting is 
BLASTN which aligns nucleotide sequences but the translated TBLASTX can 
also be used if genomes are more distantly related to each other. Aligning 
amino acids to each other can yield valid alignments even though the DNA-
sequence lacks similarity due to divergence. This has been used in a recent 
publication (Rokicki et al., 2014) where a developed software (CodaChrome) 
was used to visualize proteome conservation across thousands of genomes. 
However, that software cannot work with draft genomes and that is crucial 
during an outbreak as there will be no time to fully complete the DNA-
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sequence of the pathogen and the majority of whole-genome sequences 
available are in a draft state (Koren et al., 2013; Segerman, 2012).   
During the German enterohemorrhagic Escherichia coli O104:H4 outbreak 
in 2011, Mellmann et al. (Mellmann et al., 2011) and Rasko et al. (Rasko et al., 
2011) used NGS to characterize the outbreak strain. Both studies found that it 
was most related to the enteroaggregative strain 55989 and that the strain 
contained an interesting set of plasmids and virulence genes. In Paper II it was 
demonstrated that all of these findings could be made in Gegenees by simply 
comparing the strain to all previously sequenced E. coli strains. This 
exemplifies how Gegenees can be used for conservation analysis.  
To investigate which genomic areas that were conserved and also unique to 
B. anthracis, all whole-genome sequenced Bacillus spp. genomes were 
compared in Gegenees. The four prophages and three other shorter sequences 
were highlighted as unique for B. anthracis (Paper II). Gegenees showed that 
the prophage lambdaBa03 was basically fully conserved and unique to B. 
anthracis. This supported the PCR-design work published by Wielinga et al. in 
which the PCR was placed in this prophage (Wielinga et al., 2011b). Having a 
rapid method of assessing an outbreak pathogen is crucial for developing new 
diagnostics, for source attribution and for answering questions about peculiar 
traits (e.g., regarding antimicrobial resistances or virulence factors). For 
anthrax outbreaks, software like Gegenees can quickly indicate whether the 
outbreak strain has any peculiar genomic traits that are missing in other 
sequenced strains, or vice versa, and this brings further support into the 
investigation.  
Another useful application of Gegenees is the creation of collections of 
biomarkers instead of genomes that can contain any information the user 
supplies. For instance a set of plasmids usually found in enteric bacteria can be 
aligned together with the newly sequenced genome thus creating a rapid 
plasmid profiling for an enteric pathogen (Paper II). A similar approach was 
used by Köser et al. where an artificial methicillin-resistant Staphylococcus 
aureus (MRSA) ‘resistome’ and also a ‘toxome’ were created that contained 
resistance genes and toxin genes, respectively. Depending on the gene-content 
in the outbreak- and non-outbreak strains it created a fingerprint of the strains 
and relationships could be indicated (Köser et al., 2012). Once the toxome and 
resistome were created they could be treated as ‘genomes’ in Gegenees and the 
same graphical results would be acquired, without more manual analysis work. 
Lastly, biomarker discovery is an application that benefits from Gegenees’ 
ability to compare vast numbers of genomes as the specificity of the 
biomarkers will be assessed using all available genomic material and not just a 
subset. This feature is useful for diagnostic assay development, for instance 
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when a newly sequenced pathogen needs to be specifically detected using 
PCR. This is further discussed in 4.3. 
4.3 Evaluating PCR-assays for specificity (II and III) 
When developing a novel PCR assay or evaluating an existing one, the 
analytical specificity is one of the crucial parameters to evaluate. The 
analytical specificity includes the capability to detect all the targets and at the 
same time not give false positive reactions for non-targets (Bustin et al., 2009). 
This is often done by placing the primers and probes in a conserved gene that is 
not found in any other organisms. However, a gene that we think is unique to 
the target organism today might not be unique in the near future as more and 
more organisms are sequenced and it might be shown that the gene is found in 
a non-target organism. That is why it would be beneficial to test currently used 
assays for specificity on regular intervals. 
In the case of B. anthracis detection, the need to have specific PCR-targets 
might not be that important when analyzing a fresh blood sample because the 
likelihood of finding a close-neighbor strain that causes anthrax-like disease is 
very low. But for more complex samples like feed and environmental samples, 
e.g., soil, the issue with cross-reactivity becomes important. During the 
outbreaks in Sweden in 2008 and 2011, PCR cross-reactions were observed on 
several occasions but only for the chromosomal marker as pXO1/pXO2-like 
plasmids are uncommon (Bergman, 2011). In contrast to this, a sample of 
organic material of animal origin from India intended as ecological fertilizer 
was found PCR-positive for the virulence plasmid pXO2 in the spring of 2014 
at SVA. This case created a stressful situation as people had been in contact 
with the material and several confirmatory analyses had to be performed to 
clear the sample of suspicion (unpublished). The case stresses the importance 
of having as specific PCR-markers as possible. 
The software Gegenees (Paper II) is complemented with a short sequence 
alignment setting. This enables the alignment of a list of primers and probes to 
a database containing whole genomes. The software can sort the primer 
alignments according to the hit score against the target genomes or to the 
outgroup genomes. Its functionality was demonstrated when PCR cross-
reactions in vitro could be explained using Gegenees (Paper II).  
In order to fully elucidate how these multiple primer alignments can be used 
for diagnostic development a large scale in silico study of PCRs was initiated. 
Using Gegenees, all publically available primer/probe systems targeting B. 
anthracis were aligned to all available Bacillus spp. genomes on Genbank. 
This in silico analysis showed that there was no plasmid marker sequence that 
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was specific and that the majority of the published PCR-assays were not 
specific for the B. anthracis chromosome at all (Paper III). Since no plasmid-
marker was specific for B. anthracis, only the chromosomal targets are 
hereafter discussed. The four assays that showed 100 % specificity were all 
relatively recently published, which is not surprising as more and more 
sequence data produced give better understanding of the genomics in the 
Bacillus genus. The close neighbor strains (e.g., B. cereus G9241 (NCBI 
accession NZ_AAEK) and B. cereus var. anthracis CI (NCBI accession 
CP001746)) did, as expected, produce the majority of the cross-reactions in 
silico, at least for the assays that were relatively specific for B. anthracis. 
To further evaluate the assays an inter-laboratory trial was performed on a 
collection of DNA from 90 Bacillus spp. including some strains that are close 
neighbors to B. anthracis and also were part of the in silico analysis. To 
evaluate the in silico methodology, PCRs that were not 100 % specific were 
also included in the laboratory trial. The results from this in vitro study were 
consistent with the in silico analysis. The close neighboring strains produced 
cross reactions in vitro but three assays performed adequately, i.e., produced no 
false positive and no false negative results (Paper III).  
Interestingly, the three specific PCRs are all located within the prophage 
named ‘LambdaBa03’ in the Ames genome (NCBI accession NC_003997). 
Placing a diagnostic marker within a prophage might be considered a risk 
because of the instability of prophages (Canchaya et al., 2004). However, the 
presence of these prophages in 192 isolates from different parts of the world 
analyzed in 2006 (Sozhamannan et al., 2006) indicates that they are stable. The 
four prophages were also unique for B. anthracis when analyzed in Gegenees 
(Paper II). Still, as more and more genomes are sequenced, the assumption that 
the phages are unique to B. anthracis might have to be revised in the future. 
The chromosomal real-time PCR referred to by the WHO (WHO, 2008) 
was also included in the laboratory trial and it showed a relatively good 
specificity. However, it is based on fluorescence resonance energy transfer 
(FRET) probes and this requires certain features (i.e., decoupled 
excitation/emission filters) of real-time PCR machines that are not available on 
all machines. Hence, two of the five participating laboratories could not 
evaluate the WHO-assay. This was of course not optimal, but it does point out 
that the commonly used hydrolysis probes (e.g., Taqman) should be preferred 
since this is a more widely used technology. 
To conclude, this study demonstrates a method of evaluating PCR assays. 
Once a diagnostic PCR is in use, its specificity can be controlled by 
downloading all newly sequenced relevant genomes to Gegenees on a regular 
basis, and aligning the primer/probes to them. 
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4.4 Penicillin resistance during an anthrax outbreak (IV) 
Bacillus anthracis has two beta-lactamase genes on the chromosome but they 
are non-inducible thus making B. anthracis susceptible to penicillin (Chen et 
al., 2003). To understand how several B. anthracis isolates became penicillin 
resistant during the Swedish anthrax outbreak in 2011, six isolates were whole-
genome sequenced. They represented both penicillin susceptible and resistant 
phenotypes and by comparing their genome sequences to each other, relevant 
mutations could be determined. It was found that the reason for the penicillin 
resistance were mutations (one per resistant isolate) in the rsiP gene which 
codes for a negative extracytoplasmic sigma factor (Paper IV). Different 
frameshift mutations led to incomplete RsiP proteins. This enabled SigP, which 
is the positive sigma factor, usually sequestered by RsiP, to induce a 
constitutive expression of the two beta-lactamase genes (Paper IV). This means 
that the feedback control of this system was destroyed in the penicillin resistant 
isolates. 
One of the isolates showed a hypermutator phenotype which is described in 
detail under heading 4.5. A hypermutator has an elevated mutation rate and this 
could theoretically lead to faster development of rsiP-mutations. It has been 
shown that hypermutators play a key role in the development of antimicrobial 
resistance in Pseudomonas aeruginosa causing human lung infections (Macia 
et al., 2005). These hypermutators were found to be crucial for the 
development of a long-term chronic infection. However, hypermutators are 
associated with a loss of fitness. An in vitro study has shown that the relative 
fitness of hypermutator populations of P. aeruginosa was lowered as the 
number of generations increased and that the cause of this was only a few, 
deleterious, mutations of the many mutations accumulated (Heilbron et al., 
2014). The B. anthracis hypermutator isolate recovered in 2011 might have 
acquired its hypermutator phenotype before acquiring its resistance mutation 
thus increasing the rate of mutation and the chance of becoming resistant. 
However, only one of the resistant isolates was a hypermutator so it was not a 
prerequisite for resistance development. 
The mutation rate was estimated for one of the anthrax outbreak isolates by 
whole-genome sequencing of the isolate before and after a serial passage study 
and it was shown to be similar to a previously reported value (Vogler et al., 
2002). This implies that the outbreak strain (except for the hypermutator 
isolate) had the normal mutation rate for B. anthracis which, if proven 
otherwise, could have been a factor in why this outbreak yielded several 
independent penicillin-resistant isolates. 
By re-sequencing isolates some were found to have acquired nonsense and 
frameshift mutations in the sigP gene as well. This did, as expected, abolish the 
48 
penicillin resistance in these isolates. For one isolate, it was discovered that 
roughly 10 % of the frozen bacteria stock carried a “counter-acting” mutation. 
An amplicon sequencing experiment showed that the original blood sample 
that was sent to SVA during the outbreak contained less than 1 % of these 
mutated bacteria as it was not detected and the detection limit was about 1 % 
(Paper IV). This suggests there is some kind of enrichment of bacteria with 
counter-acting mutations during the isolation procedures used at SVA. 
Follow-up studies have been performed to clarify what the selective 
advantage might be of the counter-acting mutations. A growth rate study in 
rich medium showed no significant difference between a penicillin-resistant 
isolate and one with a counter-acting mutation. However, this growth rate 
study should have been extended with a relative competitive fitness study that 
has the resolution to confidently say anything about the possibly small changes 
in fitness. They did not show any difference in survival in -80°C or storage at 
+4°C in different commonly used buffers and they both sporulated 
successfully. 
A finding made in Paper IV was that the SigP induced transcription of a 
penicillin-binding protein (PBP) along with the beta-lactamases. This PBP is 
not expressed at all in prototypical B. anthracis strains and thus is not needed 
for normal growth. PBPs in bacteria synthesize cell-wall peptidoglycan and 
they have a strong affinity to beta-lactams (Brannigan et al., 1990; Chambers 
& Sachdeva, 1990). For MRSA it has been shown that resistance to beta-
lactams requires that a new form of PBP is acquired that has a low affinity to 
beta-lactams, thus surviving the penicillin-pressure (Pinho et al., 2001). The 
same study did however also show that the interaction between the new PBP 
and the native PBPs is complex. Since there is a strong link between cell wall 
synthesis and PBP there is a possibility that the “new” PBP affects B. anthracis 
in a way that lowers the fitness of the bacterium. If this is the case, counter-
acting mutations might also be found in this gene instead of in the sigP gene. 
Ross et al. also described a B. anthracis isolate that had an amino acid change 
in the sigP compared to all other sequenced B. anthracis strains (Ross et al., 
2009). This change presumably led to a reduced activity and the authors 
suggest that full activity of the sigma factor is detrimental to bacterial growth. 
It is tempting to assume that their isolate had acquired a missense mutation and 
the Swedish isolates acquired nonsense/frameshift mutations because the 
bacterium somehow benefits from having the penicillin resistance tuned down 
or completely shut off. This theory is slightly substantiated by the fact that all 
known sequenced B. anthracis strains have an identical DNA-sequence over 
the sigma factors thus presumably also have no expression of the beta-
lactamases and the PBP. 
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The fact that penicillin resistance in B. anthracis only requires one random 
detrimental mutation in the rsiP gene means that penicillin resistance can occur 
at any time. However, it also means that a high number of bacteria are needed 
in order to have one bacterium with that kind of mutation. The fact that the 
bacterium can revert to a sensitive phenotype once the beta-lactam pressure is 
gone, can have implications when determining the resistance in vitro. 
4.5 Heterogeneity among B. anthracis isolates during an 
outbreak (IV) 
Bacillus anthracis isolates from the 2011 outbreak in Sweden were whole-
genome sequenced to evaluate the discriminatory power needed to distinguish 
between isolates from the same outbreak. The outbreak strain’s genome was 
completed and by looking at canonical SNPs the strain belonged to the 
B.Br.001/002 lineage. Repeat regions that could have been used for MLVA or 
SNR analysis did not differ between isolates for such a short time frame of 
evolution. A genome-wide single nucleotide variant (SNV) analysis was 
performed for several isolates to determine what a “normal” genomic 
divergence during an outbreak was. Penicillin susceptible isolates had acquired 
between 1-2 unique SNVs each from the theoretical progenitor sequence 
(Paper IV).  
The in vitro mutation rate (discussed in 4.4) indicated a typical mutation 
rate for B. anthracis but when we estimated the in vivo mutation rate needed to 
yield 1-2 SNVs per isolate, it was 10-20 times higher (Paper IV). This was of 
course only a rough estimate of the true in vivo rate but it was indicative 
enough to lead us to the theory that mutations are inherited from the source. 
The source in this case was thought to be an anthrax epizootic grave from 1943 
and environmental isolates from the presumed source had also been sequenced 
in an attempt to connect the source isolates to the animal isolates. As these 
were also heterogeneous the inheritance-theory was supported. This means that 
mutations we saw 2011 might have been acquired during the 1943-outbreak or 
they may even have been inherited into the animals that died in 1943. Founder 
effects via the infectious dose can give rise to new a population which only 
inherits certain mutations from the original population.  
This led us to believe that these different SNV-populations would be 
distinguishable within an animal and this was evaluated with an amplicon 
sequencing experiment. Briefly, PCRs were designed over genomic areas 
containing the mutations and they were amplified from the different DNA-
extractions from the original blood samples sent to SVA. The amplicons were 
then sequenced and the number of reads supporting each mutation was 
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determined. This showed that the relative occurrence of the SNVs were 
between fully clonal (i.e., ~100 %) to subclonal (< 100 %) to below the 
detection limit, which was around 1 %. The detection limit was set because of 
the chance of finding a random mutation due to sequencing errors, which was 
below 1 %, although often much lower. Intra-animal spatial variation was also 
seen, which means that different clones are more or less likely to be isolated, 
depending on where the sample is extracted from the animal. 
The occurrence of a hypermutating isolate (Paper IV) is notable as this is 
uncommon and might interfere with the interpretation of a SNV-based 
analysis. Köser et al. found a hypermutator during an investigation of a 
putative outbreak of MRSA and the cause was a nonsense mutation in the 
isolate’s mutS gene (Köser et al., 2012). MutS is part of the DNA proofreading 
mismatch repair pathway and the truncation of this protein led to an elevated 
mutation rate. A similar cause was identified for the B. anthracis isolate as the 
mutL gene product was truncated (Paper IV) and MutL is a crucial component 
in the mismatch repair system for Bacillus spp. (Ginetti et al., 1996). 
Hypermutators might be discarded as not being part of the outbreak if only a 
set SNP cutoff value is used (Köser et al., 2012) and this further highlights the 
need to sequence several isolates and make a judgment based on a whole 
population of outbreak isolates. 
To conclude, a genome-wide SNV analysis was needed to differentiate the 
isolates obtained from the 2011 outbreak. There are however limitations to be 
aware of: 1) clonal heterogeneity within an animal that is in the same 
magnitude as between isolates from different animals, 2) intra-animal spatial 
heterogeneity, which has implications on sampling procedures, and 3) the fact 
that we cannot differentiate between inherited mutations and current-outbreak-
specific mutations. 
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5 Conclusions 
This thesis demonstrates different uses for genomic studies and NGS to 
improve diagnostics and facilitate outbreak investigations. The specific 
conclusions of the thesis work are: 
 
 Spores of Bacillus spp. genetically closely related to B. anthracis 
behaved phenotypically similar to B. anthracis spores thus being 
suitable model organisms. 
 Fragmented alignment was shown to be an efficient alternative to 
traditional whole-genome alignment for conservation analysis. The 
developed software, named Gegenees, can be used in an outbreak 
situation to rapidly characterize the pathogen’s genome. 
 Gegenees could be used to evaluate specificity of PCR-assays in silico 
against a large panel of genomes. 
 The reason for the B. anthracis penicillin resistance development was a 
defect rsiP gene product and counter-acting mutations in the sigP gene 
could reverse a resistant isolate back to a penicillin-susceptible 
phenotype. The ease of which resistance can occur and also disappear 
can have implications for resistance determinations. Penicillin should 
probably stay the primary choice for animal anthrax treatment but the 
risk of resistance development should be considered.  
 Several isolates from each animal from an outbreak should be sequenced 
to use SNVs for epidemiological investigations as there are risks of 
sequencing a hypermutator or a sub-clone that poorly represents the 
population in an animal. Spatial variations in the animals were found as 
the ratios of different sub-clones were different depending on where in 
the animal the sample was extracted. It was also found that inherited and 
acquired SNVs are not easily separated. NGS and genomic studies 
proved powerful tools for providing outbreak support but good reference 
data is needed to put new results in context. 
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6 Perspectives for the future 
Genomics in epidemiological investigations – retrospectively and in real-time 
 
Using WGS and genomics as tools for epidemiological investigations has been 
demonstrated for several pathogens. The Vibrio cholera outbreak on Haiti that 
followed the earthquake in 2010 was connected to Nepalese soldiers sent by 
the United Nations (Hendriksen et al., 2011). Beres et al. described how three 
successive epidemics of invasive infections of group A Streptococcus consisted 
of different strains (Beres et al., 2010). Much attention has been awarded the 
studies by Köser et al. and Harris et al. (Harris et al., 2013; Köser et al., 2012) 
in their work to explain transmissions that took place during MRSA outbreaks. 
The Harris et al. study is a retrospective descriptive study that explained the 
transmission events of the MRSA clone in the hospital. In contrast, Köser et al. 
attempted to differentiate between outbreak-associated isolates and non-
outbreak isolates during the putative outbreak itself. Real-time studies like the 
latter one can provide information that can improve treatment schemes and 
outbreak countermeasures. 
The Swedish anthrax outbreaks in 2011 and 2013 are examples of a 
retrospective study and a real-time study, respectively. After sending DNA 
from the 2011-isolates to a sequencing core-facility, the DNA-reads were 
delivered to SVA three months later. Genome finishing and comparative 
studies to fully elucidate on the SNV-heterogeneity and penicillin resistance 
then took several months. In contrast, the 2013-outbreak isolate was sequenced 
using an Illumina MiSeq available at SVA in less than 24 hours and the 
determination that the 2013-isolate was highly similar to the 2011-strain took 
30 minutes. The difference in sequencing time between the two cases stem 
from the availability of a smaller benchtop NGS machine at SVA but the 
difference in analysis time is due to reference data. If the 2011-study had not 
been so in-depth, little could have been said about the 2013-isolate. To have 
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data to compare new data to is of greatest importance and much time-
consuming work enabled the new genomic characterization in minutes. 
The NGS technology is advancing at an astounding speed. What took years 
to perform seven years ago now takes hours and the scientific community is 
still trying to keep up with this rate of progression. In the near future, DNA 
sequencing will probably be made in the field next to a sick or deceased 
animal, but these technological gains must be matched by software that can 
handle the large amount of data and put it to use. 
The primary goal for the field of B. anthracis research should be to create a 
reference database of sequencing and/or genotyping results that is shared 
between countries, starting with the countries in Europe. Secondly, 
improvements in genomic analysis software are needed as too much is 
dependent on user experience in command-line interface software that is 
developed ad hoc and has to be modified for each task. If these two goals were 
met it would enable source indications and genomic characterizations in a 
fraction of the current time and would strengthen our capacity to respond to 
future natural or antagonistic outbreaks of B. anthracis. 
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7 Populärvetenskaplig sammanfattning 
7.1 Bakgrund 
Bacillus anthracis är bakterien som orsakar sjukdomen mjältbrand, också 
kallad antrax. Sjukdomen är en zoonos, d.v.s. den kan överföras mellan djur 
och människa, men det är under naturliga förhållanden framförallt djur som 
drabbas. B. anthracis är en av få bakterier som kan omvandla sig själv till en 
överlevnadskraftig spor. Sporen är nästan helt inaktiv och kan därför ligga i 
marken och vänta på att infektera ett djur i flera decennier. Det finns till och 
med rapporter på runt 100 år gamla sporer som väckts till liv. Betande djur är 
väldigt känsliga för dessa sporer. När ett djur blir infekterat genom att andas in 
eller äta sporer som finns i fodret eller på marken så är sjukdomsförloppet 
oftast mycket snabbt och leder ofta till döden. Från det döda djuret kan det 
rinna okoagulerat blod ur kroppsöppningar och bakterierna i blodet (ofta över 
100 miljoner per ml blod) som kommer ut i syrerik atmosfär sporulerar. På 
grund av att marken, och inte djuret, är den naturliga reservoaren för dessa 
sporer så kan det vara svårt att få bort sjukdomen från ett område.  
Mjältbrand är än idag vanligt i vissa länder men i Europa sker endast 
sporadiska utbrott t.ex. när gamla mjältbrandsgravar störs, antingen genom 
grävarbete eller extrema väder. Mjältbrand var vanligt i Sverige fram till mitten 
av 1950-talet då importen av benmjöl (som användes i fodermedel) stoppades 
då detta identifierats som källan till utbrotten. Efter 27 mjältbrandsfria år bröt 
smittan ut 2008 i Veddige, Halland. Det blev en kostsam historia där över 60 
MSEK gick åt för att sanera gården m.m. 2011 utbröt sjukdomen bland betande 
kor i Kvismare naturreservat. Efter antibiotikabehandling så fortsatte ändå djur 
att dö och från dessa djur isolerades antibiotikaresistenta bakterieisolat. Genom 
markprovtagning och molekylär diagnostik försökte SVA finna källan till 
utbrottet. Eftersom B. anthracis är väldigt lik andra naturligt förekommande 
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jordbakterier kan markprover ge falskt positiva signaler då diagnostiska 
markörer kan korsreagera med dessa närbesläktade bakterier. 
Genomik kallas det när hela arvsmassan (s.k. genom) hos en organism eller 
flera studeras och jämförs. Eftersom hela arvsmassan används måste den först 
sekvenseras och detta har varit en väldigt kostsam och tidskrävande process 
men genom nya typer av sekvenseringsteknologier, som först blev tillgängliga 
2007, så kan ett helt bakteriellt genom sekvenseras på bara dagar istället för 
månader eller år som förr var fallet. Genomikstudier har utförts i de fyra 
delstudierna i denna avhandling för att förbättra diagnostik, för att smittspåra 
och för att ta reda på hur antibiotikaresistensen uppkom. 
7.2 Studier och resultat 
7.2.1 Modellsporer för övningar och metodutveckling 
Eftersom B. anthracis är patogen för människor så krävs hög nivå av 
skyddsutrustning och så kallade skyddsnivå-3-laboratorium för att få arbeta 
med bakterien. För att underlätta vid metodutveckling och för att ha ett ofarligt 
alternativ till B. anthracis vid övningar så har sporer av arten B. globigii, 
numera B. atrophaeus använts. De är dock inte alls närbesläktade med B. 
anthracis och hypotesen att mer närbesläktade arter skulle bete sig mer som B. 
anthracis testades därför. 
Det som eftersöktes var relativt ofarliga Bacillus-stammar som liknade B. 
anthracis vad gäller egenskaper som till exempel känslighet för värme. 
Genom-analyser tillsammans med analyser av en gen som heter spoIIIAB 
utfördes för att se vilka stammar som var genetiskt sett mest lika B. anthracis. 
De som var mest lika, tillsammans med mer olika arter, valdes ut och 
sporulerades. Dessa sporer jämfördes med B. anthracis-sporer angående 
värmekänslighet, svar på olika germinerande ämnen, storlek och utseende och 
växt på agarplattor som är relativt specifika för B. anthracis. 
Två stammar av arten B. cereus identifierades som extremt lika B. anthracis 
– både genomiskt och i de efterföljande experimenten. Ett oväntat resultat var 
att de även växte på agarplattor som är utvecklade för växt av B. anthracis. 
Dessa två stammar har, sedan studien publicerades, använts i flertalet 
övningar där likheten med B. anthracis gjort övningarna mer realistiska. De har 
använts i metodutvecklingar där metoden kunnat utvecklas och optimeras på 
ofarliga sporer på ett vanligt skyddsnivå-2-laboratorium för att sen testas på B. 
anthracis-sporer på ett skyddsnivå-3-laboratorium. De har också använts som 
kontroller i diagnostik av jord- och omgivningsprover från områden som haft 
mjältbrandsutbrott. 
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7.2.2 Mjukvara för att jämföra bakteriella genom 
För att dra slutsatser om en bakteries genom så hjälper det om man kan jämföra 
genomet med andra bakteriers genom. Att jämföra hela genom mot varandra är 
svårt när antalet genom överstiger cirka 20 stycken, mycket p.g.a. av att 
normala datorer inte klarar av mängden beräkningar som krävs. 
Mjukvaran Gegenees har därför utvecklats för att se konservering av 
genetiskt material mellan ett stort antal genom. Programmet delar upp DNA-
sekvenserna i små bitar och jämför alla mot alla istället för att jämföra hela 
genomen mot varandra direkt. Detta gör att en normal arbetsdator kan jämföra 
flera hundra genom samtidigt, beroende på genom-storlek. Gegenees lämpar 
sig väl för att utveckla ny diagnostik då unika områden i en bakteries DNA 
snabbt kan identifieras med programmet och specifika diagnostiska markörer 
placeras där. Gegenees kan också hjälpa användaren att hitta orsaker till extrem 
patogenicitet eller antibiotikaresistens i en bakterie. 
7.2.3 Optimera diagnostikmarkörer 
Eftersom jordprover nästan alltid innehåller andra Bacillus-arter så kan det 
skapa falskt positiva analysresultat om någon av dem innehåller DNA-
sekvenser som tidigare antagits vara unika för B. anthracis. För att säkerställa 
att så specifika markörer som möjligt används så utfördes en jämförelsestudie 
av alla publicerade DNA-markörer för detektion av B. anthracis. 
Programmet Gegenees jämförde alla markörsekvenser mot alla publikt 
tillgängliga Bacillus-genom. Sekvenserna sorterades sedan för specificitet 
vilket betyder att sekvenser som får en perfekt träff i alla B. anthracis-genom 
men inte en enda perfekt träff i andra Bacillus sorteras fram först. Tre 
markörsekvenser var enligt Gegenees 100 % specifika så de valdes ut 
tillsammans med några med lägre specificitet och markörer som WHO 
rekommenderade. Dessa markörer analyserades sedan i en ringstudie mellan 
fem europeiska laboratorier för att jämföra Gegenees-resultaten med verkliga 
analysresultat. Resultaten överensstämde mellan laboratorierna och med vad 
Gegenees förutspått. De tre teoretiskt bästa sekvenserna var även bäst i 
verkligheten. Denna metodik visade sig vara effektiv på att jämföra 
diagnostiska DNA-markörsekvenser mot varandra och kan säkerställa att bästa 
möjliga sekvenser används. 
7.2.4 Antibiotikaresistens 
Bacillus anthracis är normalt känslig för penicillin men efter 
penicillinbehandling av djuren under utbrottet 2011 så utvecklades resistens 
och resistenta bakterier isolerades från döda djur. Dessa isolat 
helgenomsekvenserades och jämfördes med isolat som fortfarande var känsliga 
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för att se vad som hänt i genomet hos de resistenta isolaten. Det visade vara en 
så kallad anti-sigmafaktor, RsiP, som hade muterats på olika sätt i olika isolat 
men med samma effekt – att denna negativa sigmafaktor inte längre fungerade. 
Denna RsiP och dess positiva sigmafaktor SigP styr uttrycket av 
betalaktamasgener som behövs för att motverka penicillinet. Att den negativa 
faktorn nu var söndermuterad ger att den positiva faktorn går på högvarv och 
betalaktamaser uttrycks hela tiden och bakterien kan inte styra detta. 
Det visade sig också att i bakterieisolat som sparats i frys så fanns det en 
subpopulation av bakterier som också hade muterade, och därmed defekta, 
positiva sigmafaktorer. Dessa bakterier var som väntat inte längre resistenta 
mot penicillin. Att det bara krävs en enda slumpmässig mutation i rsiP-genen 
för att B. anthracis ska bli resistent betyder att om det finns tillräckligt många 
bakterier så kommer någon av dem ha ”rätt” mutation för att vara resistent. 
Detta ger bakterien ingen vinst, snarare tvärtom, men när penicillin sätts in som 
behandling blir den ensam kvar och kan växa och döda djuret. Att det kan 
finnas bakterier som sen har råkat stänga av sin resistens för gott kan ha 
effekter på resistensbedömningar på laboratoriet. 
7.2.5 Smittspåra med hjälp av helgenomsekvensering 
Vid smittspårningar av bakterier så undersöks vissa områden i bakteriens 
genom som har stor variabilitet. Jämförelser av dessa kan då användas för att 
skilja mellan olika stammar. Stammar av B. anthracis från hela världen har 
väldigt låg variation och ser väldigt lika ut, genomiskt sett. Det gör att väldigt 
högupplösta metoder måste användas för att kunna skilja mellan isolat från 
olika ursprung. Helgenomsekvensering representerar den högsta nivån av 
upplösning eftersom alla baser undersöks efter mutationer som är 
diskriminerande. Under ett utbrott av B. anthracis så är det oftast en enda stam 
som infekterar en grupp djur så bakteriernas DNA är i stort sett identiskt men 
ett fåtal mutationer borde ändå uppkomma under en passage genom ett djur. 
För att kvantifiera hur många mutationer som uppkommer så 
helgenomsekvenserades flera isolat från flera olika döda djur från utbrottet i 
Kvismaren. Det visade sig att varje isolat hade åtminstone ett till två baspar 
muterade jämfört med de andra isolaten. Detta tolkades som att om identiska 
bakterier infekterar olika djur så kommer de skilja sig på en till två positioner 
efter att djuren dött. Men efter att bakterier från den troliga källan till utbrottet 
sekvenserats så var även de heterogena. Källan i detta fall misstänks vara en 
mjältbrandsgrav från 1943. Detta betyder att vi inte kan veta om mutationerna 
vi såg 2011 uppkom redan 1943 och senare ärvdes in i djuren 2011 eller om de 
faktiskt uppkom 2011. 
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Sekvenseringar av blodprover från olika delar av djuren visade att det finns 
rumsliga variationer i djuren. Det betyder att bakterier med olika mutationer 
kommer ha olika sannolikheter för att isoleras på olika provställen på djuret. 
Helgenomsekvensering för att karaktärisera ett mjältbrandsisolat visade sig 
vara effektivt men fler isolat från samma djur bör sekvenseras för att kunna dra 
slutsatser om hur populationen ser ut. Kunskap om 2011-isolaten användes när 
mjältbrand återigen påvisades 2013 på en gård inte långt från utbrottsområdet 
2011. En jämförelse av det nya isolatet mot de från 2011 gav snabbt svaret att 
det var samma stam och en ny källa till 2013-års utbrott kunde uteslutas. 
7.3 Slutsatser 
De i avhandlingen beskrivna studierna visar att man med hjälp av de senaste 
sekvenseringsteknikerna och genomikstudier avsevärt kunnat förbättra 
förutsättningarna för snabb och effektiv hantering av ett mjältbrandsutbrott. 
Diagnostiska markörer har utvärderats och modellsporer har utvecklats för att 
lättare utveckla metoder och underlätta övningar. Slutligen har genomiska 
karaktäriseringar av utbrottsisolat blivit lättare och mer kraftfulla att utföra 
under själva utbrottet. Detta kan svara på frågan om huruvida bakterierna 
kommer från ett laboratorium, har några speciella attribut eller om de är helt 
normala bakterier som förväntas kunna hittas i utbrottsområdet. 
Viktiga forsknings- och utvecklingsområden för framtiden borde vara 
användarvänligare mjukvara som kan hantera den exponentiella utvecklingen 
på själva sekvenseringsmaskinerna och upprättandet av en databas med 
genomiska data från B. anthracis-stammar. Om alla länder, i åtminstone 
Europa, samarbetade så skulle ett nytt utbrottsisolat kunna jämföras med all 
tillgänglig kunskap om tidigare stammar. Detta skulle vara väldigt viktigt även 
vid ett utbrott med antagonistiskt ursprung. 
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